Laboratory and Clinical Criteria Distinguishing Mild from Moderate Hyperthyroidism in Children
In pediatric hyperthyroidism, mild disease is defined by free T4 <50 pmol/L with mild symptomatology, while moderate disease corresponds to free T4 between 51-100 pmol/L with more pronounced clinical expression 1, 2.
Laboratory Thresholds
The classification is primarily based on free T4 (fT4) levels:
- Mild hyperthyroidism: fT4 23-50 pmol/L 2
- Moderate hyperthyroidism: fT4 51-100 pmol/L 2
- Severe hyperthyroidism: fT4 >100 pmol/L 2
For your 12-year-old patient (~53 kg), these laboratory cutoffs directly guide initial antithyroid drug dosing 1.
Clinical Features That Distinguish Severity
Beyond laboratory values, clinical expression matters significantly. The guideline explicitly links severity to symptomatology 1:
Mild Disease Indicators:
- Less pronounced tachycardia
- Minimal goiter enlargement
- Absence of atrial fibrillation
- Preserved functional status
Moderate Disease Indicators:
- More prominent tachycardia (heart rate is an independent predictor of severity) 2
- Larger goiter size 2
- Presence of asthenia (weakness/fatigue - an independent clinical variable associated with more severe disease) 2
- More pronounced hypermetabolic symptoms
Treatment Implications
The distinction between mild and moderate disease directly determines initial antithyroid drug dosing 1:
- Mild hyperthyroidism (fT4 <50 pmol/L): Start with 0.4 mg/kg/day of carbimazole (or 0.3 mg/kg/day thiamazole)
- Moderate-to-severe disease (fT4 >50 pmol/L): Start with 0.8 mg/kg/day of carbimazole (or 0.6 mg/kg/day thiamazole)
For your 53 kg patient, this translates to approximately 21 mg/day for mild disease versus 42 mg/day for moderate disease (maximum 30 mg, so would use 30 mg for moderate).
Additional Laboratory Markers of Severity
While fT4 is the primary determinant, research shows that severe hyperthyroidism (which helps contextualize the mild-moderate spectrum) is independently associated with 2:
- Elevated AST (aspartate aminotransferase)
- Elevated calcium levels
- Decreased cholesterol
- Decreased albumin
These markers are less relevant for distinguishing mild from moderate but indicate more severe tissue effects when present.
Common Pitfalls
Do not rely solely on TSH suppression - TSH remains suppressed across all severity levels and doesn't distinguish between mild and moderate disease 1. Free T4 level combined with clinical symptom severity is the appropriate classification system.
The guideline emphasizes that free T3 should also be measured because some Graves' disease cases predominantly affect T3, which could lead to underestimating severity if only T4 is checked 1.